Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Lormeau

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
Synthetic oligosaccharides having various functional domains: potent and potentially safe heparin mimeticsM Petitou, P A Driguez, P Duchaussoy, et al.
Pathologie-Biologie|January 1, 1984
[Duodenal absorption of a low molecular weight heparin in rabbits]C Doutremépuich, A Masse, C Oca, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1992
Pharmacologic properties of an unfractionated heparin butyryl derivative with long-lasting effectsS Saivin, M Petitou, J C Lormeau, et al.
Thrombosis Research|May 1, 1980
Anti-Xa active heparin oligosaccharidesJ Choay, J C Lormeau, M Petitou, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1997
Pharmacokinetic study of three synthetic AT-binding pentasaccharides in various animal species-extrapolation to humansJ P Hérault, F Donat, T Bàrzu, et al.
Thrombosis Research|October 15, 1988
Effects of increased sulfation of dermatan sulfate on its in vitro and in vivo pharmacological propertiesF Dol, C Caranobe, D Dupouy, et al.
Thrombosis and Haemostasis|April 8, 1988
Standard heparin enhances the antithrombotic activity of dermatan sulfate in the rabbit but CY 216 does notY Cadroy, F Dol, C Caranobe, et al.
The Biochemical Journal|September 1, 1981
The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studiesB Casu, P Oreste, G Torri, et al.
Thrombosis and Haemostasis|March 2, 1992
Pharmacological properties of a low molecular weight butyryl heparin derivative (C4-CY 216) with long lasting effectsS Saivin, M Petitou, J C Lormeau, et al.
Thrombosis Research|June 1, 1992
Influence of molecular weight upon the anticoagulant and pharmacokinetic properties of dermatan sulfate in the rabbitS Saivin, F Dol, C Caranobe, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
Synthetic oligosaccharides having various functional domains: potent and potentially safe heparin mimeticsM Petitou, P A Driguez, P Duchaussoy, et al.
Pathologie-Biologie|January 1, 1984
[Duodenal absorption of a low molecular weight heparin in rabbits]C Doutremépuich, A Masse, C Oca, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1992
Pharmacologic properties of an unfractionated heparin butyryl derivative with long-lasting effectsS Saivin, M Petitou, J C Lormeau, et al.
Thrombosis Research|May 1, 1980
Anti-Xa active heparin oligosaccharidesJ Choay, J C Lormeau, M Petitou, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1997
Pharmacokinetic study of three synthetic AT-binding pentasaccharides in various animal species-extrapolation to humansJ P Hérault, F Donat, T Bàrzu, et al.
Thrombosis Research|October 15, 1988
Effects of increased sulfation of dermatan sulfate on its in vitro and in vivo pharmacological propertiesF Dol, C Caranobe, D Dupouy, et al.
Thrombosis and Haemostasis|April 8, 1988
Standard heparin enhances the antithrombotic activity of dermatan sulfate in the rabbit but CY 216 does notY Cadroy, F Dol, C Caranobe, et al.
The Biochemical Journal|September 1, 1981
The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studiesB Casu, P Oreste, G Torri, et al.
Thrombosis and Haemostasis|March 2, 1992
Pharmacological properties of a low molecular weight butyryl heparin derivative (C4-CY 216) with long lasting effectsS Saivin, M Petitou, J C Lormeau, et al.
Thrombosis Research|June 1, 1992
Influence of molecular weight upon the anticoagulant and pharmacokinetic properties of dermatan sulfate in the rabbitS Saivin, F Dol, C Caranobe, et al.
Pageof 7